On October 28, 2026, UK women's health startup Bloume Health announced Bloume Clinic, a specialist digital service for chronic pelvic pain that combines psychosexual therapy, gynaecology, clinician-led support groups and a self-guided app in one coordinated model. Femtech network Women of Wearables published the release and picked it up again in its October 29 newsletter. The clinic is aimed at the conditions that sit right where gynaecology meets sex life: vulvodynia, vestibulodynia, vaginismus, dyspareunia (painful sex), endometriosis, recurrent UTIs, pudendal neuralgia and pelvic girdle pain.

Why It Matters

Sexual pain is one of the least-served areas of sexual wellness. It's common and badly under-diagnosed, and treatment often fails because no single provider owns the problem. Bloume is betting that a psychology-led, multidisciplinary model run by specialists can do better than the fragmented NHS route and generalist telehealth. It's a small company, with seed-stage funding in the low six figures, but the model is interesting. It packages chronic intimate-pain care as subscription-plus-sessions, much as menopause telehealth packaged HRT. It fits a broader pattern Afterglow has tracked: pelvic-floor hardware getting [billing codes](/stories/cosm-pessary-cpt-codes-2027), [the limits of Kegel-only advice](/stories/kegel-limits-pelvic-floor-science), and [femtech clinics that folded](/stories/femtech-clinic-failures-ovom-hale) because cash-pay demand didn't cover clinical costs. That last risk applies here too. The pricing changes between the release and the live site suggest Bloume is still testing what women will pay for. For sexual-wellness brands selling dilators, lubricants and vulvar-care products, specialist pelvic-pain clinics are a natural referral and partnership channel.

The founder is the main selling point. Dr Claudia Chisari, a chartered psychologist who lives with vulvodynia herself, completed what the company describes as the world's first PhD focused on vulvodynia at King's College London. "Chronic pelvic pain doesn't sit within any single specialism," she said, adding that her PhD's systematic review found biopsychosocial models "are consistently the most effective way to help women with these complex conditions." The clinical team includes US gynaecologist Dr Corey R. Babb, who specialises in female sexual medicine and vulvovaginal disorders. Advisers include pain psychologists Prof. Lance McCracken and Prof. Rona Moss-Morris. The release cites an estimated 1 in 7 women living with chronic pelvic pain and an average of close to seven years from first symptoms to diagnosis. Care is usually split across a gynaecologist, a physio and a psychologist who rarely coordinate.

The business model is private, cash-pay and modular. Patients can start with any service and move between them. Psychosexual therapy is £125 a session, and the app is £8.99 a month (£69 a year), and both figures match on the release and Bloume's website. Other prices differ between the two: the release lists £250 initial gynaecology consultations and £39/month support groups, while the site currently shows £70 gynaecological webinars and £45/month groups. Bloume says it has raised over £215,000 from Innovate UK and angel investors and took part in the 2024 Accelerating FemTech programme. Its website says 2,300+ women in 16 countries have used its services. The app has been available since 2025, and the release says the clinic itself opened in September 2026.

Sources

Update — 2026-11-02

Initial entry — story first created.